NETWORK META-ANALYSIS OF EFFICACY OF PEMETREXED- OR BEVACIZUMAB-BASED REGIMENS IN FIRST-LINE AND MAINTENANCE TREATMENT FOR ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
机构：[1]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China;中山大学肿瘤防治中心[2]Lilly China Drug Dev & Med Affairs Ctr, Shanghai, Peoples R China;[3]Eli Lilly & Co, Indianapolis, IN 46285 USA
出处：
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2017]版：
大类|3 区医学
小类|3 区心脏和心血管系统3 区呼吸系统
最新[2023]版：
大类|3 区医学
小类|3 区心脏和心血管系统3 区呼吸系统
第一作者：
第一作者机构：[1]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714)：
Yang Y. P.,Chen G.,Yao D.,et al.NETWORK META-ANALYSIS OF EFFICACY OF PEMETREXED- OR BEVACIZUMAB-BASED REGIMENS IN FIRST-LINE AND MAINTENANCE TREATMENT FOR ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER[J].RESPIRATORY MEDICINE.2017,132:272-272.
APA：
Yang, Y. P.,Chen, G.,Yao, D.,Wang, X.,Hu, T. L....&Zhang, L..(2017).NETWORK META-ANALYSIS OF EFFICACY OF PEMETREXED- OR BEVACIZUMAB-BASED REGIMENS IN FIRST-LINE AND MAINTENANCE TREATMENT FOR ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER.RESPIRATORY MEDICINE,132,
MLA：
Yang, Y. P.,et al."NETWORK META-ANALYSIS OF EFFICACY OF PEMETREXED- OR BEVACIZUMAB-BASED REGIMENS IN FIRST-LINE AND MAINTENANCE TREATMENT FOR ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER".RESPIRATORY MEDICINE 132.(2017):272-272
